( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dr. Yeshwant Ganpatrao Kale and Dr. Karan Singh Chandrakar*


Squamous Cell Carcinoma of the Bladder is a rare type of bladder cancer. The majority of bladder cancers are transitional cell carcinomas that arise in the urinary tract epithelium and can also occur in parts of the kidney, ureter and urethra. The majority of cases are transitional cell carcinomas affecting the tall epithelial cells lining the bladder. Squamous cell carcinoma accounts for only 3 to 7% of bladder cancers in Western countries, but in certain countries where parasites are very common (especially schistosomiasis) it is found much more. Material and Methods: Total 29 patients were included in the studies that were diagnosed. All patients underwent ultrasound examination prior to their surgery and histopathological analysis Detailed history of the patient was taken. Demographic data was recorded. Results: Out of 29 patients, 9 patients were in the high-risk category, which included TaHG, T1LG, and T1HG. And 20 patients received Bacillus Calmette-Guérin (BCG) as induction therapy. A total of 6 patients received 40 mg, 12 patients received 80 mg, and 11 patients received 120 mg of BCG. Each patient received BCG weekly for 6 weeks. Of the 12 patients with muscle-invasive bladder cancer, 17 patients underwent a radical cystectomy and standard pelvic lymph node dissection with urinary diversion. Of the 17 patients, 11 patients had orthotopic neobladder while the remaining 6 underwent illeal conduit. A total of 5 patients died during the study period. Conclusion: EUA is a valuable staging tool that is readily available to all physicians Radical cystoprostatectomy is the treatment of choice with lymph node dissection. In case of muscle is not involved, the intravesical immunotherapy with Bacillus Calmette–Guerin is given with regular surveillance cystoscopies. Given recent advances in radiotherapy and previous studies suggesting improved outcomes with radiotherapy, the role of neoadjuvant/adjuvant radiation should be re-evaluated. Immunotherapy may also improve clinical outcomes. Biomarkers and pathological prognostic factors such as staging, grading also help in improving prognosis.

Keywords: SCC, Urinary bladder, schistosomiasis, BCG, TaHG, T1LG, and T1HG.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2023 Issue has been Published, Kindly check it on


    OCTOBER issue has been successfully launched on 1 OCTOBER 2023.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database